Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Minerva Neuroscie (NQ: NERV )

2.420 +0.090 (+3.86%)
Streaming Delayed Price Updated: 9:48 AM EST, Feb 2, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 9,054
Open 2.340
Bid (Size) 2.330 (2)
Ask (Size) 2.420 (40)
Prev. Close 2.330
Today's Range 2.340 - 2.420
52wk Range 1.260 - 15.27
Shares Outstanding 5,340,193
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
12 Health Care Stocks Moving In Wednesday's After-Market Session
 
Via Benzinga
EXCLUSIVE: The Benzinga Moneymaker Series, 5 Emerging Stocks For Investors To Watch
Investors are on the hunt for undervalued, underfollowed and emerging stocks to spot opportunities. The rise of social media and retail traders gave way to countless methods to uncover new information.... 
Via Benzinga

Performance

YTD
+60.26%
+60.26%
1 Month
+60.26%
+60.26%
3 Month
-17.69%
-17.69%
6 Month
-9.71%
-9.71%
1 Year
-62.19%
-62.19%

More News

Read More
Tesla, Amazon, Minerva, Kala Pharma, Gorilla Tech: Why These 5 Stocks Are Drawing Investors' Attention Today
Via Benzinga
Nasdaq Down 100 Points; Kala Pharmaceuticals Shares Spike Higher
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Why Shares Of Chinese Companies Are Trading Lower? Here Are 54 Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Dow Tumbles 150 Points; Crude Oil Falls Sharply
Via Benzinga
US Stocks Rise; Dow Gains 100 Points
Via Benzinga
Minerva Neurosciences Announces Update on its New Drug Application (NDA) for Roluperidone for the Treatment of Negative Symptoms in Schizophrenia
From Minerva Neurosciences, Inc
Via Globe NewsWire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Greater Prevalence of Anxiety & Depressive Disorders Driving Demand for New Anti-Anxiety Drug Candidates
Via FinancialNewsMedia
Topics Retirement
Exposures Pension Product Safety
Benzinga's Top Ratings Upgrades, Downgrades For November 10, 2022
Via Benzinga
Minerva Neurosciences Reports Third Quarter 2022 Financial Results and Business Updates
From Minerva Neurosciences, Inc
Via Globe NewsWire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Minerva Neurosciences to Report Third Quarter 2022 Financial Results and Business Updates on November 9, 2022
From Minerva Neurosciences, Inc
Via Globe NewsWire
Why IBM Shares Are Trading Higher; Here Are 21 Stocks Moving Premarket
Via Benzinga
Why Minerva Neurosciences Shares Dipped By Around 70%; Here Are 90 Biggest Movers From Yesterday
Via Benzinga
Dow Rises Over 2%; S&P 500 Up 100 Points
Via Benzinga
Virgin Orbit And 4 More Short Squeeze Stocks That Could Soar This Week — Including A Stock Moving Up 968 Positions
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Nasdaq Jumps 300 Points; Bank of America Tops Q3 Estimates
Via Benzinga
Why Bank of America Shares Are Trading Higher? Here Are 66 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
GLSI, AVTE: The Top 5 Short Squeeze Stocks to Watch This Week
Via InvestorPlace
Looking Into Minerva Neurosciences's Recent Short Interest
Via Benzinga
US Stocks Open Higher; Dow Surges 500 Points
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.